MannKind develops dry powder inhaler for pulmonary hypertension treatment
Go back to MannKind develops dry powder inhaler for pulmonary hypertension treatment| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.19 -0.01 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.20 | 52 Week High | $2.51 | |||
| Open | $3.18 | 52 Week Low | $0.41 | |||
| Day High | $3.21 | P/E | N/A | |||
| Day Low | $3.09 | EPS | $-0.64 | |||
| Volume | 3,089,447 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 587.50 +2.71 (0.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $584.79 | 52 Week High | $164.04 | |||
| Open | $584.92 | 52 Week Low | $97.52 | |||
| Day High | $590.98 | P/E | 107.40 | |||
| Day Low | $576.24 | EPS | $5.47 | |||
| Volume | 637,874 | |||||



